DKK 107.2
(3.08%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 | 645 Million DKK | 113.58% |
2023 | 302 Million DKK | 109.72% |
2022 | 144 Million DKK | -57.65% |
2021 | 340 Million DKK | -20.56% |
2020 | 428 Million DKK | -14.23% |
2019 | 499 Million DKK | -11.37% |
2018 | 563 Million DKK | 25.11% |
2017 | 450 Million DKK | 26.4% |
2016 | 356 Million DKK | 50.85% |
2015 | 236 Million DKK | 19.19% |
2014 | 198 Million DKK | 33.78% |
2013 | 148 Million DKK | -1.77% |
2012 | 150.66 Million DKK | 35.33% |
2011 | 111.33 Million DKK | -3.88% |
2010 | 115.82 Million DKK | 51.69% |
2009 | 76.35 Million DKK | -11.62% |
2008 | 86.39 Million DKK | 24.76% |
2007 | 69.24 Million DKK | -16.24% |
2006 | 82.66 Million DKK | 36.42% |
2005 | 60.59 Million DKK | -4.31% |
2004 | 63.32 Million DKK | 21.08% |
2003 | 52.3 Million DKK | 47.16% |
2002 | 35.54 Million DKK | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 126 Million DKK | 29.9% |
2024 Q3 | 178 Million DKK | -8.25% |
2024 Q2 | 194 Million DKK | 53.97% |
2023 Q3 | 91 Million DKK | 97.83% |
2023 Q1 | 68 Million DKK | 1033.33% |
2023 FY | 302 Million DKK | 109.72% |
2023 Q4 | 97 Million DKK | 6.59% |
2023 Q2 | 46 Million DKK | -32.35% |
2022 Q2 | 189 Million DKK | 372.5% |
2022 FY | 144 Million DKK | -57.65% |
2022 Q3 | 53 Million DKK | -71.96% |
2022 Q4 | 6 Million DKK | -88.68% |
2022 Q1 | 40 Million DKK | 566.67% |
2021 FY | 340 Million DKK | -20.56% |
2021 Q1 | 148 Million DKK | 142.62% |
2021 Q2 | 100 Million DKK | -32.43% |
2021 Q3 | 89 Million DKK | -11.0% |
2021 Q4 | 6 Million DKK | -93.26% |
2020 Q2 | 150 Million DKK | 61.29% |
2020 FY | 428 Million DKK | -14.23% |
2020 Q4 | 61 Million DKK | -60.9% |
2020 Q3 | 156 Million DKK | 4.0% |
2020 Q1 | 93 Million DKK | 416.67% |
2019 Q2 | 200 Million DKK | 78.57% |
2019 Q1 | 112 Million DKK | -32.12% |
2019 Q4 | 18 Million DKK | -93.66% |
2019 FY | 499 Million DKK | -11.37% |
2019 Q3 | 284 Million DKK | 42.0% |
2018 Q1 | 91 Million DKK | -20.87% |
2018 FY | 563 Million DKK | 25.11% |
2018 Q2 | 144 Million DKK | 58.24% |
2018 Q3 | 151 Million DKK | 4.86% |
2018 Q4 | 165 Million DKK | 9.27% |
2017 Q3 | 101 Million DKK | -16.53% |
2017 Q1 | 65 Million DKK | -50.38% |
2017 Q4 | 115 Million DKK | 13.86% |
2017 FY | 450 Million DKK | 26.4% |
2017 Q2 | 121 Million DKK | 86.15% |
2016 Q4 | 131 Million DKK | 39.36% |
2016 Q2 | 85 Million DKK | 84.78% |
2016 Q1 | 46 Million DKK | -49.45% |
2016 FY | 356 Million DKK | 50.85% |
2016 Q3 | 94 Million DKK | 10.59% |
2015 FY | 236 Million DKK | 19.19% |
2015 Q4 | 91 Million DKK | 264.0% |
2015 Q3 | 25 Million DKK | -80.47% |
2015 Q2 | 128 Million DKK | 326.67% |
2015 Q1 | 30 Million DKK | -62.5% |
2014 Q3 | 55 Million DKK | 17.02% |
2014 Q4 | 80 Million DKK | 45.45% |
2014 FY | 198 Million DKK | 33.78% |
2014 Q1 | 16 Million DKK | -64.13% |
2014 Q2 | 47 Million DKK | 193.75% |
2013 Q3 | 24.8 Million DKK | 172.53% |
2013 Q4 | 44.6 Million DKK | 79.84% |
2013 FY | 148 Million DKK | -1.77% |
2013 Q1 | 21.4 Million DKK | -55.94% |
2013 Q2 | 9.1 Million DKK | -57.48% |
2012 Q2 | 39.9 Million DKK | 53.46% |
2012 Q1 | 26 Million DKK | 120.66% |
2012 FY | 150.66 Million DKK | 35.33% |
2012 Q4 | 48.56 Million DKK | 34.16% |
2012 Q3 | 36.2 Million DKK | -9.27% |
2011 Q4 | 11.78 Million DKK | -65.55% |
2011 Q2 | 67.4 Million DKK | 132.41% |
2011 FY | 111.33 Million DKK | -3.88% |
2011 Q1 | 29 Million DKK | -9.72% |
2011 Q3 | 34.2 Million DKK | -49.26% |
2010 Q1 | 18.7 Million DKK | 200.26% |
2010 Q2 | 32.4 Million DKK | 73.26% |
2010 FY | 115.82 Million DKK | 51.69% |
2010 Q4 | 32.12 Million DKK | -1.46% |
2010 Q3 | 32.6 Million DKK | 0.62% |
2009 Q4 | 6.22 Million DKK | -80.35% |
2009 Q1 | 22.3 Million DKK | 0.0% |
2009 Q2 | 34.6 Million DKK | 55.16% |
2009 FY | 76.35 Million DKK | -11.62% |
2009 Q3 | 31.7 Million DKK | -8.38% |
2008 FY | 86.39 Million DKK | 24.76% |
2007 FY | 69.24 Million DKK | -16.24% |
2006 FY | 82.66 Million DKK | 36.42% |
2005 FY | 60.59 Million DKK | -4.31% |
2004 FY | 63.32 Million DKK | 21.08% |
2003 FY | 52.3 Million DKK | 47.16% |
2002 FY | 35.54 Million DKK | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
ChemoMetec A/S | 178.78 Million DKK | -260.775% |
Demant A/S | 4.14 Billion DKK | 84.45% |
GN Store Nord A/S | 869 Million DKK | 25.777% |
Scandinavian Medical Solutions A/S | 16.62 Million DKK | -3779.316% |
ViroGates A/S | -12.56 Million DKK | 5233.307% |